Filing Details
- Accession Number:
- 0001209191-19-013741
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-26 18:23:49
- Reporting Period:
- 2019-02-22
- Accepted Time:
- 2019-02-26 18:23:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1667633 | Forty Seven Inc. | FTSV | Pharmaceutical Preparations (2834) | 474065674 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1743839 | Ravindra Majeti | C/O Forty Seven, Inc. 1490 O'Brien Drive, Suite A Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-02-22 | 22,371 | $16.01 | 1,495,977 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-25 | 10,266 | $16.07 | 1,485,711 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan.
- The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $16.00 to $16.06, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 3.
- The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $16.00 to $16.35, inclusive.
Billionaire Hedge Funds
